Literature DB >> 27068727

Unmasking the elusive giant: an unusual case presenting as third nerve palsy in a patient with scleroderma.

Wan Lin Ng1, John McManus2, James Anthony Joseph Devlin1, Alexander Fraser1.   

Abstract

We report a case of an 80-year-old woman being treated with rituximab and maintenance corticosteroids for long-standing scleroderma who presented with right-sided third nerve palsy. Radiological investigations including CT, MRI and MR angiography of the brain were unremarkable. The patient was discharged with a diagnosis of probable microvascular third nerve palsy but was readmitted 1 week later with total visual loss in her left eye. Despite the absence of diagnostic clinical signs, giant cell arteritis (GCA) was suspected, and she was started on intravenous corticosteroids. Left temporal artery biopsy subsequently confirmed histological findings diagnostic of GCA. Unfortunately, she remained blind in the left eye. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27068727      PMCID: PMC4840633          DOI: 10.1136/bcr-2016-214633

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  37 in total

1.  Giant cell arteritis, oculomotor nerve palsy, and acute hearing loss.

Authors:  L Loffredo; S Parrotto; F Violi
Journal:  Scand J Rheumatol       Date:  2004       Impact factor: 3.641

2.  BSR and BHPR guidelines for the management of giant cell arteritis.

Authors:  Bhaskar Dasgupta; Frances A Borg; Nada Hassan; Leslie Alexander; Kevin Barraclough; Brian Bourke; Joan Fulcher; Jane Hollywood; Andrew Hutchings; Pat James; Valerie Kyle; Jennifer Nott; Michael Power; Ash Samanta
Journal:  Rheumatology (Oxford)       Date:  2010-04-05       Impact factor: 7.580

3.  Treatment of refractory temporal arteritis with adalimumab.

Authors:  M Mubashir Ahmed; Eisha Mubashir; Samina Hayat; Marjorie Fowler; Seth Mark Berney
Journal:  Clin Rheumatol       Date:  2006-08-30       Impact factor: 2.980

4.  Simultaneous ischemic optic neuropathy and third cranial nerve palsy in giant cell arteritis.

Authors:  Cağatay Oncel; Ferda Bir; L Sinan Bir
Journal:  J Neuroophthalmol       Date:  2007-12       Impact factor: 3.042

5.  Rituximab-induced leukocytoclastic vasculitis: a case report.

Authors:  Praveen Kandula; Peter A Kouides
Journal:  Arch Dermatol       Date:  2006-02

6.  Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis.

Authors:  F David Carmona; Aurora Serrano; Luis Rodríguez-Rodríguez; José Luis Callejas; Carmen P Simeón; Patricia Carreira; Santos Castañeda; Roser Solans; Ricardo Blanco; Miguel A González-Gay; Javier Martín
Journal:  J Rheumatol       Date:  2012-05-15       Impact factor: 4.666

7.  Interleukin 6 blockade as steroid-sparing treatment for 2 patients with giant cell arteritis.

Authors:  Savino Sciascia; Daniela Rossi; Dario Roccatello
Journal:  J Rheumatol       Date:  2011-09       Impact factor: 4.666

8.  Bilateral recurrent optic neuropathy with unilateral oculomotor nerve palsy in giant cell arteritis.

Authors:  Nurgül Örnek; Ersel Dağ; Nesrin Büyüktortop; Reyhan Oğurel; Kemal Örnek
Journal:  Ocul Immunol Inflamm       Date:  2012-12-19       Impact factor: 3.070

9.  Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.

Authors:  S Unizony; L Arias-Urdaneta; E Miloslavsky; S Arvikar; A Khosroshahi; B Keroack; J R Stone; J H Stone
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-11       Impact factor: 4.794

10.  [Third nerve palsy as the only manifestation of occult temporal arteritis].

Authors:  V M Asensio-Sánchez; I Morales-Gómez; I Rodríguez-Vaca
Journal:  Arch Soc Esp Oftalmol       Date:  2009-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.